documents: FDA-2022-N-2390-0588

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0588 FDA FDA-2022-N-2390 Letter from FDA OC to McDermott Will & Emery (on behalf of Vanda Pharmaceuticals Inc.) and FDA OCC Other Letter(s) 2026-03-03T05:00:00Z 2026 3 2026-03-03T05:00:00Z   2026-03-04T01:46:34Z   0 0 09000064b91ed918

Links from other tables